Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease

PURPOSE: Immune globulins for IgG supplementation have been produced for over 35 years with essentially no differentiating features regarding their specific antibody composition. Furthermore, the compositions of plasma donor pools used for IG manufacturing are not standardized. While all immune glob...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasserman, Richard L., Lumry, William, Harris, James, Levy, Robyn, Stein, Mark, Forbes, Lisa, Cunningham-Rundles, Charlotte, Melamed, Isaac, Kobayashi, Ai Lan, Du, Wei, Kobayashi, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940435/
https://www.ncbi.nlm.nih.gov/pubmed/27324887
http://dx.doi.org/10.1007/s10875-016-0308-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940435/
https://www.ncbi.nlm.nih.gov/pubmed/27324887
http://dx.doi.org/10.1007/s10875-016-0308-z

Ejemplares similares